Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak
Open Access
- 1 May 2021
- journal article
- editorial
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 4, 100099
Abstract
No abstract availableFunding Information
- European Cooperation in Science and Technology (CA19132)
This publication has 8 references indexed in Scilit:
- Relation of Statin Use Prior to Admission to Severity and Recovery Among COVID-19 InpatientsThe American Journal of Cardiology, 2020
- The impact of novel coronavirus COVID‐19 on noncommunicable disease patients and health systems: a reviewJournal of Internal Medicine, 2020
- Impact of COVID-19 on loneliness, mental health, and health service utilisation: a prospective cohort study of older adults with multimorbidity in primary careBritish Journal of General Practice, 2020
- Offline: COVID-19 is not a pandemicThe Lancet, 2020
- A wave of non-communicable diseases following the COVID-19 pandemicDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Twin epidemics of covid-19 and non-communicable diseaseBMJ, 2020
- Prevention and control of non-communicable diseases in the COVID-19 responseThe Lancet, 2020
- Non-communicable disease management in vulnerable patients during Covid-19Indian Journal of Medical Ethics, 2020